Symbols / CTNM Stock $12.42 -4.17% Contineum Therapeutics, Inc.

Healthcare • Biotechnology • United States • NMS
CTNM (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: SMA 50: SMA 200:
About

No company description available for this symbol.

Stock Fundamentals
Scroll to Statements
Market Cap 463.71M Enterprise Value 209.07M Income -59.98M Sales Book/sh 6.99 Cash/sh 7.04
Dividend Yield Payout 0.00% Employees 51 IPO P/E Forward P/E -5.71
PEG P/S P/B 1.78 P/C EV/EBITDA -3.09 EV/Sales
Quick Ratio 26.98 Current Ratio 27.50 Debt/Eq 3.16 LT Debt/Eq EPS (ttm) -2.17 EPS next Y -2.17
EPS Growth Revenue Growth Earnings 2026-05-13 ROA -17.38% ROE -26.13% ROIC
Gross Margin 0.00% Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 32.67M Shs Float 25.36M Short Float 9.11%
Short Ratio 7.36 Short Interest 52W High 16.33 52W Low 3.35 Beta 1.39 Avg Volume 290.48K
Volume 86.47K Target Price $22.00 Recom None Prev Close $12.96 Price $12.42 Change -4.17%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
Mean price target
2. Current target
Latest analyst target
3. DCF / Fair value
$-20.34
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
Low
High
Mean

No recent news from Yahoo. Try the RSS feed for latest CTNM news.

Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-06 LORRAIN DANIEL S. PH.D. Officer 4,170 $13.43 $56,014
2026-03-02 LORRAIN DANIEL S. PH.D. Officer 4,170 $15.01 $62,585
2026-03-02 WATKINS TIMOTHY M.D. Officer 3,611 $15.02 $54,220
2026-03-02 WATKINS TIMOTHY M.D. Officer 3,611 $4.50 $16,250
2026-02-25 STENGONE CARMINE N Chief Executive Officer 7,100 $16.02 $113,728
2026-02-25 STENGONE CARMINE N Chief Executive Officer 7,100 $1.26 $8,946
2026-02-25 LORRAIN DANIEL S. PH.D. Officer 8,124 $16.01 $130,164
2026-02-25 LORRAIN DANIEL S. PH.D. Officer 8,124 $1.01 $8,205
2026-02-19 LORRAIN DANIEL S. PH.D. Officer 100 $16.00 $1,600
2026-02-19 LORRAIN DANIEL S. PH.D. Officer 100 $1.01 $101
Financials

No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.

SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category